Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Shares of Encompass Health Co. (NYSE:EHC – Get Rating) have earned an average recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $64.13.
Several equities research analysts recently issued reports on EHC shares. StockNews.com started coverage on Encompass Health in a research note on Wednesday, October 12th. They set a “hold” rating for the company. TheStreet raised Encompass Health from a “c+” rating to a “b-” rating in a research note on Wednesday, December 21st. Stephens dropped their price target on Encompass Health from $60.00 to $58.00 and set an “overweight” rating for the company in a research note on Friday, October 28th. Credit Suisse Group dropped their price target on Encompass Health from $63.00 to $62.00 and set an “outperform” rating for the company in a research note on Wednesday, September 21st. Finally, Raymond James lifted their price target on Encompass Health from $65.00 to $72.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 28th.
Insider Transactions at Encompass Health
In other Encompass Health news, Director Greg D. Carmichael purchased 1,830 shares of Encompass Health stock in a transaction that occurred on Monday, October 31st. The shares were bought at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the acquisition, the director now directly owns 10,546 shares in the company, valued at $576,549.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.70% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of EHC. Worth Asset Management LLC purchased a new position in shares of Encompass Health during the 1st quarter worth approximately $35,000. Wipfli Financial Advisors LLC purchased a new position in shares of Encompass Health during the 3rd quarter worth approximately $25,000. CWM LLC grew its holdings in shares of Encompass Health by 67.6% during the 3rd quarter. CWM LLC now owns 625 shares of the company’s stock worth $28,000 after acquiring an additional 252 shares during the period. Eagle Bay Advisors LLC grew its holdings in shares of Encompass Health by 137.5% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,019 shares of the company’s stock worth $57,000 after acquiring an additional 590 shares during the period. Finally, Financial Gravity Asset Management Inc. grew its holdings in shares of Encompass Health by 452.1% during the 2nd quarter. Financial Gravity Asset Management Inc. now owns 1,176 shares of the company’s stock worth $2,201,000 after acquiring an additional 963 shares during the period. Hedge funds and other institutional investors own 96.14% of the company’s stock.
Encompass Health Price Performance
Shares of NYSE EHC opened at $59.30 on Monday. The stock has a market cap of $5.92 billion, a PE ratio of 21.80, a price-to-earnings-growth ratio of 2.90 and a beta of 1.06. Encompass Health has a fifty-two week low of $44.33 and a fifty-two week high of $74.61. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.21 and a current ratio of 1.21. The stock has a fifty day moving average of $55.27 and a 200-day moving average of $52.40.
Encompass Health (NYSE:EHC – Get Rating) last posted its quarterly earnings data on Wednesday, October 26th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.01). The business had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.06 billion. Encompass Health had a net margin of 5.39% and a return on equity of 15.59%. Equities research analysts anticipate that Encompass Health will post 2.79 earnings per share for the current year.
Encompass Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be issued a $0.15 dividend. The ex-dividend date of this dividend is Friday, December 30th. This represents a $0.60 annualized dividend and a dividend yield of 1.01%. Encompass Health’s dividend payout ratio is currently 22.06%.
About Encompass Health
(Get Rating)
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Further Reading
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Encompass Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Encompass Health wasn’t on the list.
While Encompass Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today’s challenging market? Click the link below and we’ll send you MarketBeat’s list of ten stocks that will drive in any economic environment.
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Enter your email address below to learn when Elon Musk will let these companies finally IPO.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
